Citigroup, Bank of America, and BNP Paribas issued rating updates and price targets for AbbVie stock on August 13, 2026.
2 reports, 2 independent
Updated Sep 22
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup, Bank of America, and BNP Paribas issued rating updates and price targets for AbbVie stock on August 13, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
AbbVie
pharmaceutical company
-
Citigroup
American investment bank and financial services corporation
-
Bank of America
American multinational banking and financial services corporation
-
Paribas
French investment bank (1872-2000)
Nothing else this week.
Related events
- Citigroup and Royal Bank of Canada raised price targets and ratings for a company, with MarketBeat aggregating the financial data.
- Analyst coverage for Vornado Realty Trust resulted in rating changes and price target adjustments from firms including Citigroup, Morgan Stanley, and Truist Financial.
- Bank of America, Citigroup, and Royal Bank of Canada issued rating upgrades and price target increases for International Paper.
- Bank of America raised its buy rating and price objective, while Citigroup raised its target price and gave a neutral rating for Ford Motor Company.
- Citigroup and Truist Financial issued buy ratings and increased price targets for Cisco.